The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2Susanne Krasemann, Ole Pleß, Antje Appelt‐Menzel et al.|Stem Cell Reports|2022Cited by 239
Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cellsLisa Epping, Sven G. Meuth, Christina B. Schroeter et al.|Cellular and Molecular Life Sciences|2022Cited by 25
Transport of Non-Steroidal Anti-Inflammatory Drugs across an Oral Mucosa Epithelium In Vitro ModelGrace C. Lin, Winfried Neuhaus|Pharmaceutics|2024Cited by 1